ETROLIZUMAB TREATMENT MODULATES MADCAM-1 LEVELS IN SERUM IN PATIENTS WITH CROHN’S DISEASE
Conference
UEG Week 2018
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]
Social Sharing